Digital Age: Otsuka Sets Sights On Abilify Combo Tablet With Sensor
This article was originally published in The Pink Sheet Daily
First-of-its-kind NDA is for a combination product of Abilify embedded with an ingestible sensor to measure adherence and physiologic response. Otsuka sees opportunities to extend brand facing generic competition and for combo approach with future medicines too.
Register for our free email digests: